Agency Information Collection Activities; Proposed Collection; Comment Request; Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products, 26281-26283 [2012-10645]
Download as PDF
Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email: pso@AHRQ.hhs.
gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, Public Law
109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety Rule, 42
CFR Part 3, authorizes AHRQ, on behalf
of the Secretary of HHS, to list as a PSO
an entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule.
Section 3.108(d) of the Patient Safety
Rule requires AHRQ to provide public
notice when it removes an organization
from the list of federally approved
PSOs, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason. Accordingly,
CareRise LLC, PSO number P0058, was
delisted effective at 12:00 Midnight ET
(2400) on March 30, 2012.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/index.
html.
Dated: April 24, 2012.
Carolyn M. Clancy,
Director.
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
National Advisory Council for
Healthcare Research and Quality:
Request for Nominations for Public
Members
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of request for
nominations for public members.
wreier-aviles on DSK7SPTVN1PROD with NOTICES
AGENCY:
42 U.S.C. 299c establishes a
National Advisory Council for
Healthcare Research and Quality (the
Council). The Council is to advise the
Secretary of HHS (Secretary) and the
Director of the Agency for Healthcare
Research and Quality (AHRQ) on
SUMMARY:
15:32 May 02, 2012
Nominations should be sent
to Ms. Karen Brooks, AHRQ, 540
Gaither Road, Room 3006, Rockville,
Maryland 20850. Nominations may also
be emailed to
Karen.Brooks@ahrq.hhs.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jkt 226001
Ms.
Karen Brooks, AHRQ, at (301) 427–
1801.
42 U.S.C.
299c provides that the Secretary shall
appoint to the National Advisory
Council for Healthcare Research and
Quality twenty one appropriately
qualified individuals. At least seventeen
members shall be representatives of the
public and at least one member shall be
a specialist in the rural aspects of one
or more of the professions or fields
listed in the above summary. In
addition, the Secretary designates, as ex
officio members, representatives from
other Federal agencies, principally
agencies that conduct or support health
care research, as well as Federal officials
the Secretary may consider appropriate.
42 U.S.C. 299c(c)(3). The Council meets
in the Washington, DC, metropolitan
area, generally in Rockville, Maryland,
approximately three times a year to
provide broad guidance to the Secretary
and AHRQ’s Director on the direction of
and programs undertaken by AHRQ.
Seven individuals will be selected
presently by the Secretary to serve on
the Council beginning with the meeting
in the spring of 2012. Members
SUPPLEMENTARY INFORMATION:
[FR Doc. 2012–10596 Filed 5–2–12; 8:45 am]
VerDate Mar<15>2010
matters related to activities of the
Agency to improve the quality, safety,
efficiency, and effectiveness of health
care for all Americans.
Seven current members’ terms will
expire in November 2012. To fill these
positions, we are seeking individuals
who are distinguished: (1) In the
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) in the fields of health
care quality research or health care
improvement; (3) in the practice of
medicine; (4) in other health
professions; (5) in representing the
private health care sector (including
health plans, providers, and purchasers)
or administrators of health care delivery
systems; (6) in the fields of health care
economics, information systems, law,
ethics, business, or public policy; and,
(7) in representing the interests of
patients and consumers of health care.
42 U.S.C. 299c(c)(2). Individuals are
particularly sought with experience and
success in activities specified in the
summary above.
DATES: Nominations should be received
on or before 60 days after date of
publication.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
26281
generally serve 3-year terms.
Appointments are staggered to permit
an orderly rotation of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that once you are
nominated, AHRQ may consider your
nomination for future positions on the
Council. Federally registered lobbyists
are not permitted to serve on this
advisory board pursuant to the
Presidential Memorandum entitled
‘‘Lobbyists on Agency Boards and
Commissions’’ dated June 10, 2010, and
the Office of Management and Budget’s
‘‘Final Guidance on Appointment of
Lobbyists to Federal Boards and
Commissions,’’ 76 FR 61756 (October 5,
2011).
The Department seeks a broad
geographic representation. In addition,
AHRQ conducts and supports research
concerning priority populations, which
include: Low-income groups; minority
groups; women; children; the elderly;
and individuals with special health care
needs, including individuals with
disabilities and individuals who need
chronic care or end-of-life health care.
See 42 U.S.C. 299(c). Nominations of
persons with expertise in health care for
these priority populations are
encouraged.
Dated: April 24, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–10595 Filed 5–2–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No.FDA–2012–N–0386]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Registration and
Product Listing for Owners and
Operators of Domestic Tobacco
Product Establishments and Listing of
Ingredients in Tobacco Products
AGENCY:
Food and Drug Administration,
HHS.
E:\FR\FM\03MYN1.SGM
03MYN1
26282
ACTION:
Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the proposed extension of an existing
collection of information pertaining to
registration and product listing for
owners and operators of domestic
tobacco product establishments and to
listing of ingredients in tobacco
products under the Family Smoking
Prevention and Tobacco Control Act
(the Tobacco Control Act).
DATES: Submit either electronic or
written comments on the collection of
information by July 2, 2012.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, daniel.gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
wreier-aviles on DSK7SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:32 May 02, 2012
Jkt 226001
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Registration and Product Listing for
Owners and Operators of Domestic
Tobacco Product Establishments and
Listing of Ingredients in Tobacco
Products (OMB Control Number 0910–
0650)—Extension
On June 22, 2009, the President
signed the Tobacco Control Act (Pub. L.
111–31) into law. The Tobacco Control
Act amended the Federal Food, Drug,
and Cosmetic Act (the FD&C Act) (21
U.S.C. 301 et seq.) by, among other
things, adding a new chapter granting
the FDA important new authority to
regulate the manufacture, marketing,
and distribution of tobacco products to
protect the public health generally and
to reduce tobacco use by minors.
Section 905(b) of the FD&C Act (21
U.S.C. 395(b)), as amended by the
Tobacco Control Act, requires that
‘‘every person who owns or operates
any establishment in any State engaged
in the manufacture, preparation,
compounding, or processing of a
tobacco product or tobacco products
* * *’’ register with the FDA the name,
places of business, and all
establishments owned operated by that
person. Every person must register by
December 31 of each year. Section
905(c) of the FD&C Act requires that
first-time persons ‘‘engaging in the
manufacture, preparation,
compounding, or processing of a
tobacco product or tobacco products
shall register with the Secretary the
name, places of business, and all such
establishments of that person.’’ Section
905(d) states that persons required to
register under sections 905(b) or 905(c)
shall register any additional
establishment that they own or operate
in any state which begins the
manufacture, preparation,
compounding, or processing of a
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
tobacco product or tobacco products.
Section 905(h) addresses foreign
establishment registration requirements,
which will go into effect when
regulations are promulgated by the
Secretary. Section 905(i)(1) of the FD&C
Act, as amended by the Tobacco Control
Act, requires that all registrants ‘‘shall,
at the time of registration under any
such subsection, file with [FDA] a list of
all tobacco products which are being
manufactured, prepared, compounded,
or processed by that person for
commercial distribution,’’ along with
certain accompanying consumer
information, such as all labeling and a
representative sampling of
advertisements. Section 904(a)(1) of the
FD&C Act, as amended by the Tobacco
Control Act, requires each tobacco
product manufacturer or importer, or
agent thereof, to submit ‘‘a listing of all
ingredients, including tobacco,
substances, compounds, and additives
that are * * * added by the
manufacturer to the tobacco, paper,
filter, or other part of each tobacco
product by brand or by quantity in each
brand and subbrand.’’ Since the
Tobacco Control Act was enacted on
June 22, 2009, the information required
under section 904(a)(1) must be
submitted to FDA by December 22,
2009, and include the ingredients added
as of the date of submission. Section
904(c) of the FD&C Act also requires
submission of information whenever
additives, or the quantities of additives,
are changed.
FDA issued guidance documents on
both: (1) Registration and Product
Listing for Owners and Operators of
Domestic Tobacco Product
Establishments (November 12, 2009, 74
FR 58298) and (2) Listing of Ingredients
in Tobacco Products (December 1, 2009,
74 FR 62795) to assist persons making
such submissions to FDA under the
Tobacco Control Act. While electronic
submission of registration and product
listing information and ingredient
listing information are not required,
FDA is strongly encouraging electronic
submission to facilitate efficiency and
timeliness of data management and
collection. To that end, FDA designed
the eSubmitter application to streamline
the data entry process for registration
and product listing and for ingredient
listing. This tool allows for importation
of large quantities of structured data,
attachment of files (e.g., in portable
document format (PDFs) and certain
media files), and automatic
acknowledgement of FDA’s receipt of
submissions. FDA also developed paper
forms (Form FDA 3742—Registration
and Listing for Owners and Operators of
E:\FR\FM\03MYN1.SGM
03MYN1
26283
Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices
Domestic Tobacco Product
Establishments and Form FDA 3743—
Listing of Ingredients in Tobacco
Products) as an alternative submission
tool. Both the eSubmitter application
and the paper forms can be accessed at
https://www.fda.gov/tobacco.
FDA form/
activity/TCA section
Number of
respondents
Number of responses per
respondent
FDA estimates the burden of this
collection of information as follows:
Total annual
responses
Hours per
response
Total hours
Form FDA 3742 Registration and Product Listing for Owners and Operators of Domestic Establishments (Electronic and Paper submission) Sections 905(b), 905(c),
905(d) 905(h), or 905(i) ....................................................
Form FDA 3743 Listing of Ingredients (Electronic and
Paper Submissions) Sections 904(a)(1) or 904(c) ..........
Obtaining a DUNS Number (10% of total respondents) .....
125
1.6
200
3.75
750
125
8
1.6
1
200
8
3.00
0.50
600
4
Total ..............................................................................
........................
........................
........................
........................
1,354
wreier-aviles on DSK7SPTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Since this collection of information
was last approved by OMB on December
2, 2010, its burden has decreased by
407,421 hours, from 408,775 to 1,354
reporting hours. This adjustment is a
result of FDA experience over the past
2 years in the regulation of tobacco
products and is based on the actual
number of establishment registration
and product ingredient submissions
received during this time period. In
2010, when this collection was first
published for public comment in the
Federal Register, FDA attempted to
determine the actual number of tobacco
manufacturers by using the Security and
Exchange Commission’s Standard
Industrial Classification (SIC) codes,
which are identifying codes that appear
in a company’s EDGAR filings to show
the company’s type of business. When
preparing the collection of information
package for publication in 2010, the
tobacco industry codes indicated that
over 10,000 tobacco manufacturers
existed under the SIC codes for tobacco
products and cigarettes. However, upon
further examination of these codes, it
appears that the number of tobacco
manufacturers was greatly inflated, as
the SIC codes included tobacco retail in
addition to tobacco manufacturers. In
addition, no comments were received
from the 2010 initial 60-Day Federal
Register Notice regarding either the
number of respondents or the number of
reporting burden hours listed in the
notice, so FDA used the collection’s
SIC-researched manufacturer numbers
for this collection of information. Actual
FDA registration and product listing
report submissions and FDA experience
indicate in the past 2 years, the number
of tobacco manufacturers required to
register and list their products and
ingredient listings is approximately 125,
a substantial decrease from the number
of potential respondents listed in 2010.
By applying the revised number of
VerDate Mar<15>2010
15:32 May 02, 2012
Jkt 226001
manufacturers to the burden chart, the
total burden for registration and listing
now is currently estimated to be 1,354
reporting burden hours, much less than
the 408,775 OMB-approved reporting
burden hours stated in 2010.
Based on the actual number of
registration and product ingredient
listing reports received by FDA over the
past 2 years, the number of expected
annual responses is projected to
decrease from 100,000 registration
responses to 200 annual responses, and
from 11,000 annual product ingredient
listing responses to 200 annual product
ingredient responses. The Agency bases
its estimate on the actual number of
registration and listing and product
ingredient listing reports received, its
experience with the submission of
registration and listing requirements
applicable to other FDA regulated
products, and ongoing interactions with
industry. FDA estimates that the
submission of registration information
as required by section 905 of the FD&C
Act will remain at 3.75 hours per
establishment. Based on the actual
number of registration information
submitted over the past 2 years and its
experience, the Agency estimates that
approximately 200 registrations will be
submitted from 125 tobacco product
establishments annually, for a total 750
hour burden (125 respondents × 1.6
responses per respondent × 3.75 hours
per response).
FDA estimates that the submission of
ingredient listing information as
required by section 904 of the FD&C Act
will remain at 3.0 hours per tobacco
product. Based on the actual number of
product ingredient listings submitted
over the past 2 years and its experience,
the Agency estimates that
approximately 200 ingredient listings
will be submitted from 125 tobacco
establishments, for a total 600 burden
hours (125 respondents × 1.6 responses
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
per respondent × 3.0 hours per
response).
FDA estimates that obtaining a Dun
and Bradstreet (DUNS) number will take
0.5 hours, and that 8 respondents (1
percent (1.25) of establishments
required to register under section 905
and 5 percent (6.25) of submitters
required to list ingredients under
section 904) will not already have a
DUNS number. The total burden,
therefore, will be 4 hours (8 respondents
× 1 response per respondent × 0.5 hours
per response).
Total burden hours for this collection,
therefore is 1,354 hours (750 + 600 + 4
hours).
Dated: April 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012–10645 Filed 5–2–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0781]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Record Retention
Requirements for the Soy Protein and
Risk of Coronary Heart Disease Health
Claim
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
E:\FR\FM\03MYN1.SGM
03MYN1
Agencies
[Federal Register Volume 77, Number 86 (Thursday, May 3, 2012)]
[Notices]
[Pages 26281-26283]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10645]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No.FDA-2012-N-0386]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Registration and Product Listing for Owners and
Operators of Domestic Tobacco Product Establishments and Listing of
Ingredients in Tobacco Products
AGENCY: Food and Drug Administration, HHS.
[[Page 26282]]
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the proposed extension of an
existing collection of information pertaining to registration and
product listing for owners and operators of domestic tobacco product
establishments and to listing of ingredients in tobacco products under
the Family Smoking Prevention and Tobacco Control Act (the Tobacco
Control Act).
DATES: Submit either electronic or written comments on the collection
of information by July 2, 2012.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-5156,
daniel.gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Registration and Product Listing for Owners and Operators of Domestic
Tobacco Product Establishments and Listing of Ingredients in Tobacco
Products (OMB Control Number 0910-0650)--Extension
On June 22, 2009, the President signed the Tobacco Control Act
(Pub. L. 111-31) into law. The Tobacco Control Act amended the Federal
Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 301 et seq.) by,
among other things, adding a new chapter granting the FDA important new
authority to regulate the manufacture, marketing, and distribution of
tobacco products to protect the public health generally and to reduce
tobacco use by minors.
Section 905(b) of the FD&C Act (21 U.S.C. 395(b)), as amended by
the Tobacco Control Act, requires that ``every person who owns or
operates any establishment in any State engaged in the manufacture,
preparation, compounding, or processing of a tobacco product or tobacco
products * * *'' register with the FDA the name, places of business,
and all establishments owned operated by that person. Every person must
register by December 31 of each year. Section 905(c) of the FD&C Act
requires that first-time persons ``engaging in the manufacture,
preparation, compounding, or processing of a tobacco product or tobacco
products shall register with the Secretary the name, places of
business, and all such establishments of that person.'' Section 905(d)
states that persons required to register under sections 905(b) or
905(c) shall register any additional establishment that they own or
operate in any state which begins the manufacture, preparation,
compounding, or processing of a tobacco product or tobacco products.
Section 905(h) addresses foreign establishment registration
requirements, which will go into effect when regulations are
promulgated by the Secretary. Section 905(i)(1) of the FD&C Act, as
amended by the Tobacco Control Act, requires that all registrants
``shall, at the time of registration under any such subsection, file
with [FDA] a list of all tobacco products which are being manufactured,
prepared, compounded, or processed by that person for commercial
distribution,'' along with certain accompanying consumer information,
such as all labeling and a representative sampling of advertisements.
Section 904(a)(1) of the FD&C Act, as amended by the Tobacco Control
Act, requires each tobacco product manufacturer or importer, or agent
thereof, to submit ``a listing of all ingredients, including tobacco,
substances, compounds, and additives that are * * * added by the
manufacturer to the tobacco, paper, filter, or other part of each
tobacco product by brand or by quantity in each brand and subbrand.''
Since the Tobacco Control Act was enacted on June 22, 2009, the
information required under section 904(a)(1) must be submitted to FDA
by December 22, 2009, and include the ingredients added as of the date
of submission. Section 904(c) of the FD&C Act also requires submission
of information whenever additives, or the quantities of additives, are
changed.
FDA issued guidance documents on both: (1) Registration and Product
Listing for Owners and Operators of Domestic Tobacco Product
Establishments (November 12, 2009, 74 FR 58298) and (2) Listing of
Ingredients in Tobacco Products (December 1, 2009, 74 FR 62795) to
assist persons making such submissions to FDA under the Tobacco Control
Act. While electronic submission of registration and product listing
information and ingredient listing information are not required, FDA is
strongly encouraging electronic submission to facilitate efficiency and
timeliness of data management and collection. To that end, FDA designed
the eSubmitter application to streamline the data entry process for
registration and product listing and for ingredient listing. This tool
allows for importation of large quantities of structured data,
attachment of files (e.g., in portable document format (PDFs) and
certain media files), and automatic acknowledgement of FDA's receipt of
submissions. FDA also developed paper forms (Form FDA 3742--
Registration and Listing for Owners and Operators of
[[Page 26283]]
Domestic Tobacco Product Establishments and Form FDA 3743--Listing of
Ingredients in Tobacco Products) as an alternative submission tool.
Both the eSubmitter application and the paper forms can be accessed at
https://www.fda.gov/tobacco.
FDA estimates the burden of this collection of information as
follows:
----------------------------------------------------------------------------------------------------------------
Number of
FDA form/ activity/TCA section Number of responses per Total annual Hours per Total hours
respondents respondent responses response
----------------------------------------------------------------------------------------------------------------
Form FDA 3742 Registration and 125 1.6 200 3.75 750
Product Listing for Owners and
Operators of Domestic
Establishments (Electronic and
Paper submission) Sections
905(b), 905(c), 905(d) 905(h),
or 905(i).......................
Form FDA 3743 Listing of 125 1.6 200 3.00 600
Ingredients (Electronic and
Paper Submissions) Sections
904(a)(1) or 904(c).............
Obtaining a DUNS Number (10% of 8 1 8 0.50 4
total respondents)..............
------------------------------------------------------------------------------
Total........................ .............. ............. .............. .............. 1,354
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Since this collection of information was last approved by OMB on
December 2, 2010, its burden has decreased by 407,421 hours, from
408,775 to 1,354 reporting hours. This adjustment is a result of FDA
experience over the past 2 years in the regulation of tobacco products
and is based on the actual number of establishment registration and
product ingredient submissions received during this time period. In
2010, when this collection was first published for public comment in
the Federal Register, FDA attempted to determine the actual number of
tobacco manufacturers by using the Security and Exchange Commission's
Standard Industrial Classification (SIC) codes, which are identifying
codes that appear in a company's EDGAR filings to show the company's
type of business. When preparing the collection of information package
for publication in 2010, the tobacco industry codes indicated that over
10,000 tobacco manufacturers existed under the SIC codes for tobacco
products and cigarettes. However, upon further examination of these
codes, it appears that the number of tobacco manufacturers was greatly
inflated, as the SIC codes included tobacco retail in addition to
tobacco manufacturers. In addition, no comments were received from the
2010 initial 60-Day Federal Register Notice regarding either the number
of respondents or the number of reporting burden hours listed in the
notice, so FDA used the collection's SIC-researched manufacturer
numbers for this collection of information. Actual FDA registration and
product listing report submissions and FDA experience indicate in the
past 2 years, the number of tobacco manufacturers required to register
and list their products and ingredient listings is approximately 125, a
substantial decrease from the number of potential respondents listed in
2010. By applying the revised number of manufacturers to the burden
chart, the total burden for registration and listing now is currently
estimated to be 1,354 reporting burden hours, much less than the
408,775 OMB-approved reporting burden hours stated in 2010.
Based on the actual number of registration and product ingredient
listing reports received by FDA over the past 2 years, the number of
expected annual responses is projected to decrease from 100,000
registration responses to 200 annual responses, and from 11,000 annual
product ingredient listing responses to 200 annual product ingredient
responses. The Agency bases its estimate on the actual number of
registration and listing and product ingredient listing reports
received, its experience with the submission of registration and
listing requirements applicable to other FDA regulated products, and
ongoing interactions with industry. FDA estimates that the submission
of registration information as required by section 905 of the FD&C Act
will remain at 3.75 hours per establishment. Based on the actual number
of registration information submitted over the past 2 years and its
experience, the Agency estimates that approximately 200 registrations
will be submitted from 125 tobacco product establishments annually, for
a total 750 hour burden (125 respondents x 1.6 responses per respondent
x 3.75 hours per response).
FDA estimates that the submission of ingredient listing information
as required by section 904 of the FD&C Act will remain at 3.0 hours per
tobacco product. Based on the actual number of product ingredient
listings submitted over the past 2 years and its experience, the Agency
estimates that approximately 200 ingredient listings will be submitted
from 125 tobacco establishments, for a total 600 burden hours (125
respondents x 1.6 responses per respondent x 3.0 hours per response).
FDA estimates that obtaining a Dun and Bradstreet (DUNS) number
will take 0.5 hours, and that 8 respondents (1 percent (1.25) of
establishments required to register under section 905 and 5 percent
(6.25) of submitters required to list ingredients under section 904)
will not already have a DUNS number. The total burden, therefore, will
be 4 hours (8 respondents x 1 response per respondent x 0.5 hours per
response).
Total burden hours for this collection, therefore is 1,354 hours
(750 + 600 + 4 hours).
Dated: April 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-10645 Filed 5-2-12; 8:45 am]
BILLING CODE 4160-01-P